Publication Name	World Journal of Clinical Cases
Manuscript ID	79054
Country	China

Received	2022-07-30 15:09
Peer-Review Started	2022-07-30 15:10
To Make the First Decision
Return for Revision	2022-09-03 10:32
Revised	2022-09-07 15:58
Second Decision	2022-09-26 03:20
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2022-09-27 01:11
Articles in Press	2022-09-27 01:11
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-10-12 02:12
Publish the Manuscript Online	2022-10-27 04:55

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Intestinal microbiota in the treatment of metabolically associated fatty liver disease
Manuscript Source	Unsolicited Manuscript
All Author List	Ji-Shuai Wang and Jin-Chun Liu
ORCID	Author(s) ORCID Number Jin-Chun Liu http://orcid.org/0000-0002-1984-6802
Funding Agency and Grant Number	Funding Agency Grant Number Scientific and Technological Achievements Transformation Guidance Special of Shanxi Province in China 201904D131030
Corresponding Author	Jin-Chun Liu, MD, Chief Doctor, Full Professor, Department of Gastroenterology, The First Hospital of Shanxi Medical University, No. 85 Jiefangnan Road, Taiyuan 030001, Shanxi Province, China. zxr610624@163.com
Key Words	Intestinal microbiota; Metabolically associated fatty liver disease; Gut-liver axis; Adipokines; Therapy
Core Tip	Recent animal studies and Clinical researches have placed the gut microbiota as a potentially important player in the pathogenesis of metabolically associated fatty liver disease (MAFLD).It is logical to target  the gut microbiota to develop new strategies for MAFLD therapy.In addition, we assessed the therapeutic potential of intestinal microbiota manipulation for treating MAFLD and discussed the specific doses and duration of use can provide more help for clinicians in choosing treatment options.
Publish Date	2022-10-27 04:55
Citation	Wang JS, Liu JC. Intestinal microbiota in the treatment of metabolically associated fatty liver disease. World J Clin Cases 2022; 10(31):11240-11251
URL	https://www.wjgnet.com/2307-8960/full/v10/i31/11240.htm
DOI	https://dx.doi.org/10.12998/wjcc.v10.i31.11240

Full Article (PDF)	WJCC-10-11240.pdf
Full Article (Word)	WJCC-10-11240.docx
Manuscript File	79054_Auto_Edited-JLW.docx
Answering Reviewers	79054-Answering reviewers.pdf
Audio Core Tip	79054-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	79054-Conflict-of-interest statement.pdf
Copyright License Agreement	79054-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	79054-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate	79054-Language certificate.pdf
Peer-review Report	79054-Peer-review(s).pdf
Scientific Misconduct Check	79054-Bing-Wang LL-2.png
Scientific Editor Work List	79054-Scientific editor work list.pdf
CrossCheck Report	79054-CrossCheck report.pdf